CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-23 | Powell Andrew Kenneth William Director | Gift | −5,500 | 11,209 | ||
| 2021-11-01 | Foresite Capital Management III, LLC 10% owner | Other disposition | −1,954,904 | 0 | ||
| 2021-11-01 | Foresite Capital Management III, LLC 10% owner | Other acquisition | +8,276 | 8,276 | ||
| 2021-09-01 | Monahan Joseph Chief Scientific Officer | Option exercise | +2,333 | 87,675 | ||
| 2021-09-01 | Monahan Joseph Chief Scientific Officer | Shares withheld for taxes | −1,041 | $17.22 | $18K | 86,634 |
| 2021-09-01 | Monahan Joseph Chief Scientific Officer | Option exercise · Restricted Stock Units | −2,333 | 0 | ||
| 2021-07-13 | Gordon David N. Chief Medical Officer | Sale | −2,631 | $16.98 | $45K | 147,447 |
| 2021-07-02 | Gordon David N. Chief Medical Officer | Option exercise | +6,000 | 150,078 | ||
| 2021-07-02 | Gordon David N. Chief Medical Officer | Option exercise · Restricted Stock Units | −6,000 | 6,000 | ||
| 2021-06-03 | SCHIFF ANDREW N Director | Grant or award · Stock Option (Right to Buy) | +12,250 | 12,250 | ||
| 2021-06-03 | SCHIFF ANDREW N Director | Grant or award · Restricted Stock Units | +3,356 | 3,356 | ||
| 2021-06-03 | Reasons Bryan M. Director | Grant or award · Stock Option (Right to Buy) | +12,250 | 12,250 | ||
| 2021-06-03 | Reasons Bryan M. Director | Grant or award · Restricted Stock Units | +3,356 | 3,356 | ||
| 2021-06-03 | Powell Andrew Kenneth William Director | Grant or award · Stock Option (Right to Buy) | +12,250 | 12,250 | ||
| 2021-06-03 | Powell Andrew Kenneth William Director | Grant or award · Restricted Stock Units | +3,356 | 3,356 | ||
| 2021-06-03 | Molineaux Christopher P. Director | Grant or award · Stock Option (Right to Buy) | +12,250 | 12,250 | ||
| 2021-06-03 | Molineaux Christopher P. Director | Grant or award · Restricted Stock Units | +3,356 | 3,356 | ||
| 2021-06-03 | MILANO VINCENT Director | Grant or award · Stock Option (Right to Buy) | +12,250 | 12,250 | ||
| 2021-06-03 | MILANO VINCENT Director | Grant or award · Restricted Stock Units | +3,356 | 3,356 | ||
| 2021-06-03 | Mehra Anand Director | Grant or award · Stock Option (Right to Buy) | +12,250 | 12,250 |
Page 28 of 34 · 680 trades